Experimental studies demonstrated that FGF21 prevented cardiac hypertrophy by activating silent information regulator 1 (Sirt1) signaling through the activation of FGFR1c with β-Klotho as a co-receptor10. This evidence concerns the gene FGF21 and cardiac hypertrophy.